• Alda 1: Advancing ALDH2 Activation for Cardiac Regeneration

  2026-04-30

  This article explores the transformative role of Alda 1, a potent ALDH2 activator from APExBIO, in enabling next-generation research on cardioprotection, cardiac regeneration, and radiation-induced dermatitis mitigation. Integrating mechanistic insights, recent in vivo findings, and strategic protocol guidance, we delineate how Alda 1 is redefining translational research workflows and expanding the boundaries of aldehyde detoxification science.

• ZNF263 Drives Autophagy and Proliferation in Intrahepatic Ch

  2026-04-30

  This study identifies Zinc Finger Protein 263 (ZNF263) as a key driver of intrahepatic cholangiocarcinoma (ICC) cell proliferation, acting through direct transcriptional upregulation of ULK1 and subsequent enhancement of autophagy. These findings clarify a mechanistic link between transcriptional control and autophagy in ICC, offering new directions for targeted therapeutic strategies.

• FLAG tag Peptide (DYKDDDDK): Precision in Protein Purificati

  2026-04-29

  The FLAG tag Peptide (DYKDDDDK) unlocks high-specificity detection and gentle purification for recombinant proteins, outperforming conventional tags in complex workflows. This guide delivers actionable, evidence-based protocols and troubleshooting strategies that leverage APExBIO’s peptide for maximal yield and reproducibility.

• Veratridine in Mechanistic Excitotoxicity: From Sodium Chann

  2026-04-29

  Explore how Veratridine, a voltage-gated sodium channel opener, uniquely enables mechanistic dissection of excitotoxicity and disease modeling. This article delivers advanced protocol guidance, translational insight, and a critical review of contemporary research tools.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-04-28

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, closely replicating tumor microenvironment heterogeneity. The model enhances the physiological relevance of preclinical drug testing and provides new avenues for studying drug resistance and personalized therapy response.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-04-28

  Lyso-Tracker Red from APExBIO delivers highly specific, robust lysosome labeling for live cell analysis. This probe enables dynamic, quantitative studies of lysosomal distribution, morphology, and function, empowering advanced workflows in disease modeling and therapy development.

• Entecavir (BMS200475): Potent Inhibitor of Chronic HBV Repli

  2026-04-27

  Entecavir is a potent and selective inhibitor of hepatitis B virus (HBV) DNA polymerase, offering robust inhibition of both wild-type and resistant HBV strains. Clinically, it achieves sustained viral suppression with a low resistance rate and a favorable safety profile. Entecavir (SKU BA1816) from APExBIO is validated for research and therapeutic use in chronic hepatitis B infection.

• Dietary Arachidonic Acid Enhances Vaccine-Induced Humoral Im

  2026-04-27

  This study demonstrates that dietary supplementation with arachidonic acid (ARA) significantly accelerates and augments humoral immune responses to rabies vaccination in both mice and humans. Mechanistic insights reveal that ARA metabolites, particularly prostaglandin I2, amplify B cell activation in germinal centers, offering a scientifically grounded strategy to optimize vaccine efficacy through nutritional modulation.

• LY2228820: Precision p38 MAP Kinase Inhibitor for Translatio

  2026-04-26

  LY2228820 empowers scientists with unmatched selectivity and potency for precise p38 MAPK pathway interrogation in inflammation and cancer research. This guide reveals actionable protocol upgrades, advanced use-cases, and troubleshooting tactics that harness the full translational value of this ATP-competitive inhibitor.

• Berberrubine Chloride: Applied Workflows for Cancer Research

  2026-04-25

  Berberrubine chloride stands out as a multi-targeted, DMSO-soluble research chemical for investigating colorectal and non-small cell lung cancer. Its selective inhibition of TrxR and IMPDH2 enables innovative assay protocols and combinational therapy studies, with APExBIO providing reliable, assay-ready material for reproducible results.

• CUDC-907: Practical Guide for Dual PI3K and HDAC Inhibition

  2026-04-24

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for in vitro research on cancer-related signaling pathways. It enables controlled, simultaneous modulation of PI3K/AKT and histone deacetylase activity, particularly in cell-based assays. This compound is not intended for diagnostic or medical use and should be restricted to validated laboratory models.

• CTCF Safeguards Centromere Integrity and Mitotic Accuracy

  2026-04-24

  This study reveals that CTCF, a chromatin looping factor, is crucial for maintaining centromere structure and fidelity during mitosis. Using rapid depletion models, the authors show that CTCF loss disrupts chromosome alignment and nuclear shape, providing mechanistic insight relevant for mitosis-focused cancer research.

• Inflammation in Ischemic Stroke: Biomarkers and Intervention

  2026-04-23

  Xiao et al. (2025) provide a comprehensive synthesis of the roles that inflammation and immune markers play in ischemic stroke (IS) pathogenesis, progression, and treatment. Their review uniquely integrates the mechanistic basis of neuroinflammation with evolving diagnostic and therapeutic strategies, facilitating nuanced experimental and clinical advancements.

• LLY507: Deep Mechanistic Insights and Protocol Guidance for

  2026-04-23

  Explore LLY-507, a highly selective SMYD2 inhibitor, with a mechanistic deep dive and practical protocol guidance. This article uniquely bridges molecular action to advanced assay design, empowering apoptosis and cancer cell proliferation inhibition research.

• Phosbind Biotin: Next-Level Phosphorylation Analysis in Sign

  2026-04-22

  Discover how Phosbind Biotin, powered by dinuclear metal complex phosphate binding, advances Western Blot detection of phosphorylated proteins—enabling deeper insights into signal transduction and post-translational modification research.

16217 records 1/1082 page Next 12345 下5页 Last page